blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4281474

EP4281474 - DUAL BINDING ANTIBODIES, METHODS OF PRODUCING DUAL BINDING ANTIBODIES, AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.10.2023
Database last updated on 27.07.2024
FormerThe international publication has been made
Status updated on  29.07.2022
Most recent event   Tooltip22.03.2024Change: Validation statespublished on 24.04.2024  [2024/17]
22.03.2024Change - extension statespublished on 24.04.2024  [2024/17]
Applicant(s)For all designated states
Biolojic Design Ltd.
Hamada 12, Building B, 3rd Floor
P.O. Box 4106
Rehovot 7670316 / IL
[2023/48]
Inventor(s)01 / DEMISHTEIN, Alik
4805638 Rosh Haayin / IL
02 / OMER, Dotan
4343314 Ra'anana / IL
03 / BERNSTEIN, Shmuel
7124901 Lod / IL
04 / LEVIN, Itay
4642758 Herzeliya / IL
05 / SASSON, Yehezkel
4486200 Tzur Yigal / IL
06 / STRAJBL, Marek
9330746 Jerusalem / IL
07 / FISCHMAN, Sharon
7176237 Modi'in / IL
08 / NIMROD, Guy
6226118 Tel Aviv / IL
09 / ZHENIN, Michael
9658603 Jerusalem / IL
10 / BARAK FUCHS, Reut
7608625 Rehovot / IL
11 / BLUVSHTEIN YERMOLAEV, Olga
7575120 Rishon-LeZion / IL
12 / FASTMAN, Yair
9655225 Jerusalem / IL
13 / TWITO, Oshrat Shir
7571807 Rishon LeTsiyon / IL
14 / OFRAN, Yanay
6215421 Tel Aviv / IL
 [2023/48]
Representative(s)Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
[2023/48]
Application number, filing date22742378.720.01.2022
[2023/48]
WO2022IL50087
Priority number, dateUS202163139815P21.01.2021         Original published format: US 202163139815 P
US202163195021P30.05.2021         Original published format: US 202163195021 P
US202263295905P02.01.2022         Original published format: US 202263295905 P
[2023/48]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2022157773
Date:28.07.2022
Language:EN
[2022/30]
Type: A2 Application without search report 
No.:EP4281474
Date:29.11.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 28.07.2022 takes the place of the publication of the European patent application.
[2023/48]
Search report(s)International search report - published on:US01.12.2022
ClassificationIPC:C07K16/18, C12N15/09, C12Q1/68, C40B30/06, C40B30/10, C40B40/06
[2023/48]
CPC:
C07K16/244 (EP); C07K16/2818 (EP,US); C07K16/005 (EP);
C07K16/2875 (US); C07K16/2878 (EP,US); C07K2317/31 (EP,US);
C07K2317/56 (EP); C07K2317/565 (EP,US); C07K2317/622 (EP,US);
C07K2317/76 (EP); C07K2317/92 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/48]
TitleGerman:DUAL-BINDENDE ANTIKÖRPER, VERFAHREN ZUR HERSTELLUNG VON DUAL-BINDENDEN ANTIKÖRPERN UND VERWENDUNGEN DAVON[2023/48]
English:DUAL BINDING ANTIBODIES, METHODS OF PRODUCING DUAL BINDING ANTIBODIES, AND USES THEREOF[2023/48]
French:ANTICORPS À LIAISON DOUBLE, PROCÉDÉS DE PRODUCTION D'ANTICORPS À LIAISON DOUBLE ET LEURS UTILISATIONS[2023/48]
Entry into regional phase04.08.2023National basic fee paid 
04.08.2023Search fee paid 
04.08.2023Designation fee(s) paid 
04.08.2023Examination fee paid 
Examination procedure04.08.2023Amendment by applicant (claims and/or description)
04.08.2023Examination requested  [2023/48]
Fees paidRenewal fee
04.08.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2009304693  (GHAYUR TARIQ [US], et al) [A] 22* ; entire document *;
 [A]US2017342144  (WEI RONNIE [US], et al) [A] 1-22 * ; paragraph 0008, 0042, 0048, 0052 *;
 [A]WO2017220988  (KYMAB LTD [GB]) [A] 1-22 * ; pg. 16, lines 30-32 *;
 [A]WO2021001653  (OXFORD BIOTHERAPEUTICS LTD [GB]) [A] 1-22 * ; p. 32, line 1, pg. 6, lines 27-28, pg. 7, lines 3-4 *;
 [A]  - FELLOUSE FREDERIC A ET AL, "High-throughput Generation of Synthetic Antibodies from Highly Functional Minimalist Phage-displayed Libraries.", Journal of Molecular Biology, Academic Press, United Kingdom, United Kingdom , (20071102), vol. 373, no. 4, doi:10.1016/j.jmb.2007.08.005, ISSN 0022-2836, pages 924 - 940, XP002457179 [A] 1-22

DOI:   http://dx.doi.org/10.1016/j.jmb.2007.08.005
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.